GBIO
Price
$0.30
Change
-$0.06 (-16.67%)
Updated
Jun 27 closing price
Capitalization
22.46M
38 days until earnings call
INTS
Price
$0.31
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
8.45M
50 days until earnings call
Interact to see
Advertisement

GBIO vs INTS

Header iconGBIO vs INTS Comparison
Open Charts GBIO vs INTSBanner chart's image
Generation Bio
Price$0.30
Change-$0.06 (-16.67%)
Volume$7.39M
Capitalization22.46M
Intensity Therapeutics
Price$0.31
Change-$0.00 (-0.00%)
Volume$12.67K
Capitalization8.45M
GBIO vs INTS Comparison Chart in %
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. INTS commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a Hold and INTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (GBIO: $0.30 vs. INTS: $0.31)
Brand notoriety: GBIO and INTS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 1118% vs. INTS: 1%
Market capitalization -- GBIO: $22.46M vs. INTS: $8.45M
GBIO [@Biotechnology] is valued at $22.46M. INTS’s [@Biotechnology] market capitalization is $8.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileINTS’s FA Score has 0 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • INTS’s FA Score: 0 green, 5 red.
According to our system of comparison, INTS is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 3 TA indicator(s) are bullish while INTS’s TA Score has 3 bullish TA indicator(s).

  • GBIO’s TA Score: 3 bullish, 5 bearish.
  • INTS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, INTS is a better buy in the short-term than GBIO.

Price Growth

GBIO (@Biotechnology) experienced а -20.95% price change this week, while INTS (@Biotechnology) price change was +10.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

GBIO is expected to report earnings on Aug 06, 2025.

INTS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GBIO($22.5M) has a higher market cap than INTS($8.45M). GBIO YTD gains are higher at: -71.660 vs. INTS (-82.614). INTS has higher annual earnings (EBITDA): -14.92M vs. GBIO (-69.2M). GBIO has more cash in the bank: 158M vs. INTS (929K). INTS has less debt than GBIO: INTS (131K) vs GBIO (87.6M). GBIO has higher revenues than INTS: GBIO (24.6M) vs INTS (0).
GBIOINTSGBIO / INTS
Capitalization22.5M8.45M266%
EBITDA-69.2M-14.92M464%
Gain YTD-71.660-82.61487%
P/E RatioN/AN/A-
Revenue24.6M0-
Total Cash158M929K17,008%
Total Debt87.6M131K66,870%
TECHNICAL ANALYSIS
Technical Analysis
GBIOINTS
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
58%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
58%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BPRN31.590.76
+2.47%
Princeton Bancorp
BL56.640.11
+0.19%
BlackLine
GHLD19.73N/A
N/A
Guild Holdings Company
GEHC74.38-0.48
-0.64%
GE HealthCare Technologies
FGEN5.22-0.08
-1.51%
FibroGen Inc

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-15.40%
CCCC - GBIO
50%
Loosely correlated
-7.89%
ATXS - GBIO
50%
Loosely correlated
N/A
IDYA - GBIO
48%
Loosely correlated
-4.13%
ATNM - GBIO
48%
Loosely correlated
-12.35%
IPSC - GBIO
47%
Loosely correlated
-5.74%
More

INTS and

Correlation & Price change

A.I.dvisor tells us that INTS and GBIO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and GBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTS
1D Price
Change %
INTS100%
N/A
GBIO - INTS
29%
Poorly correlated
-15.40%
MRKR - INTS
29%
Poorly correlated
N/A
ACAD - INTS
28%
Poorly correlated
-0.41%
GPCR - INTS
27%
Poorly correlated
N/A
CCCC - INTS
27%
Poorly correlated
-7.89%
More